SK Bioscience secures first EU vaccine project with IDT

SK Bioscience said Wednesday it has secured its first European Union-backed vaccine development project alongside German subsidiary IDT Biologika, marking a key milestone one year after the acquisition. The company was selected for Phase 1 of a next-generation vaccine initiative led by the European Health and Digital Executive Agency (HaDEA) under the European Health Emergency Preparedness and Response Authority. SK Bioscience and IDT will participate in a consortium with Australian vaccine plat

By The Korea Herald